Eargo to Report First Quarter 2021 Financial Results on May 12, 2021
Eargo, a medical device company focused on improving hearing loss solutions, will announce its Q1 2021 financial results on May 12, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Eargo, a medical device company focused on improving hearing loss solutions, will announce its Q1 2021 financial results on May 12, 2021, after market close. A conference call will follow at 2:00 p.m. PT to discuss these results. Eargo offers virtually invisible, rechargeable hearing aids that are FDA regulated and cost approximately half of traditional hearing aids. Their latest product, the Eargo Neo HiFi, launched in January 2020, provides enhanced audio capabilities. More details are available on Eargo's website.
Positive
- Eargo's hearing aids are offered at approximately half the cost of traditional competitors.
- The launch of Eargo Neo HiFi with improved audio fidelity enhances product offering.
Negative
- None.
Details
News Market Reaction – EAR
The recorded move for EAR in the trading session of this news was -2.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the first quarter 2021 after market close on May 12, 2021. On the same day, Eargo will host a conference call and webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its financial results and recent highlights.
Interested parties may access the live call via telephone by dialing (833) 649-1234 for domestic callers or (914) 987-7293 for international callers, using conference ID: 3971939. The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargo’s website at ir.eargo.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Eargo’s website for one year.
About Eargo
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I or Class II devices for the treatment of hearing loss. Our differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.
The company’s 4th generation product, the Eargo Neo HiFi, was launched in January 2020 and features improved capabilities across audio fidelity and bandwidth. The Eargo Neo HiFi is available for purchase here.
Related Links
http://eargo.com
Investor Contact
Nick Laudico
Vice President of Investor Relations
ir@eargo.com
Media Contact
Brad Sheets
eargo@edelman.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.